Provided by Tiger Trade Technology Pte. Ltd.

LENSAR Inc

12.01
0.0000
Post-market: 12.010.00000.00%17:21 EST
Volume:88.21K
Turnover:1.06M
Market Cap:143.45M
PE:-2.76
High:12.15
Open:12.01
Low:11.84
Close:12.01
52wk High:17.31
52wk Low:7.25
Shares:11.94M
Float Shares:8.64M
Volume Ratio:1.55
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3490
EPS(LYR):-2.7265
ROE:-422.35%
ROA:-8.17%
PB:-5.54
PE(LYR):-4.40

Loading ...

Company Profile

Company Name:
LENSAR Inc
Exchange:
NASDAQ
Establishment Date:
2004
Employees:
140
Office Location:
2800 Discovery Drive,Orlando,Florida,United States
Zip Code:
32826
Fax:
- -
Introduction:
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Directors

Name
Position
Nicholas T. Curtis
Chief Executive Officer and Director
William J. Link
Chairperson and Director
Aimee S. Weisner
Director
Elizabeth G. O'Farrell
Director
Gary M. Winer
Director
Richard L. Lindstrom
Director
Thomas B. Ellis
Director
Todd B. Hammer
Director

Shareholders

Name
Position
Nicholas T. Curtis
Chief Executive Officer and Director
Alan B. Connaughton
Chief Operating Officer
Thomas R. Staab, II
Chief Financial Officer and Secretary